Rho is proud to announce Becky Baggett, Associate Vice President, Project Delivery and Ben Vaughn, Chief Strategist, Biostatistics & Protocol Design to present “Interim Analyses in Acute Pain Trials:  Maximizing your chances of success and accelerating drug development” at the Pain Therapeutics Summit.

With nearly 40,000 patients treated in over 260 studies and 2,400 sites, our expertise navigating the unique challenges associated with analgesia drug development is not only helpful, it’s crucial. We are passionate about helping others live a pain free life. As a conference sponsor, we look forward to collaborating with industry leaders and sharing our expertise with others to advance new therapies.

Want to learn more? Contact us at info@rhoworld.com to connect with our experts.